The pattern of venture capital investing has changed radically since the 2013. The key change is that the group of investments of over $100 million is now close to becoming the predominant class of venture capital deployed in the life sciences.
There is a clear trend towards the deployment of large amounts of capital in venture investing. In 2013, there were only three life science venture capital rounds worth over $100...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?